Pfizer Inc Stock Forecast for 2023 - 2025 - 2030

Updated on 04/01/2023

Stock Rating
3
Price Target
$52.65
Consensus
Outperform
Upside
29.08%
Analysts
8
Stock Rating
3
Upside
29.08%
Analysts
8
Price Target
$52.65

Pfizer Inc Stock Forecast and Price Target

The average target price for Pfizer Inc's stock set by eight renowned analysts in recent months is $52.65, representing a potential upside of approximately 29.08% from its last closing price if met by 2024. This estimation is based on a high estimate of $75.00 and a low estimate of $44.00. If you are looking to invest in the stock, it's important to research and compare different companies.

$52.65

29.08% Upside

Outperform
Outperform

Pfizer Inc Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, Pfizer Inc's Price has grown by 89.49%, from $36.70 to $69.54. 19 analysts predict Pfizer Inc's Fair Value will decrease by 2.33% in the next year, reaching $67.92. By 2030, professionals predict that Pfizer Inc's Fair Value will decrease by 42.04%, to $40.31.

2023 Fair Value Forecast
$67.92
2024 Fair Value Forecast
$56.10
2025 Fair Value Forecast
$53.99
2026 Fair Value Forecast
$52.50
2027 Fair Value Forecast
$52.87
2028 Fair Value Forecast
$43.42
2029 Fair Value Forecast
$40.31
2030 Fair Value Forecast
$40.31
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
JNJ Stock Forecast Johnson & Johnson Outperform 10
$154.95 $181.05 16.49%
LLY Stock Forecast Eli Lilly and Outperform 16
$343.42 $333.19 16.48%
MRK Stock Forecast Merck Outperform 5
$106.38 $99.57 10.92%
BMY Stock Forecast Bristol-Myers Squibb Co Outperform 2
$69.31 $80.99 19.75%
REGN Stock Forecast Regeneron Pharmaceuticals Inc Outperform 2
$821.67 $796.73 -4.83%

Pfizer Inc Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Pfizer Inc's Revenue has grown by 145.28%, from $40.91B to $100.33B. 17 analysts predict Pfizer Inc's Revenue will decrease by 20.35% in the next year, reaching $79.92B. By 2030, professionals predict that Pfizer Inc's Revenue will decrease by 47.10%, to $53.07B.

2023 Rev Forecast
$79.92B
2024 Rev Forecast
$69.26B
2025 Rev Forecast
$67.30B
2026 Rev Forecast
$65.06B
2027 Rev Forecast
$64.48B
2028 Rev Forecast
$55.63B
2029 Rev Forecast
$53.31B
2030 Rev Forecast
$53.07B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
VRTX Stock Forecast Vertex Pharmaceuticals Inc Outperform 16
$315.03 $323.74 3.48%
ZTS Stock Forecast Zoetis Outperform 18
$166.42 $209.70 23.18%
BAX Stock Forecast Baxter International Inc Outperform 17
$40.56 $60.73 43.00%

Pfizer Inc Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, Pfizer Inc's Dividend per Share has grown from $1.44 to $1.64 – a 13.89% increase. Next year, analysts are expecting Dividend per Share to reach $1.68 – an increase of 2.44%. Over the next eight years, the forecast is for Dividend per Share to grow by 3.05%.

2023 DPS Forecast
$1.68
2024 DPS Forecast
$1.72
2025 DPS Forecast
$1.77
2026 DPS Forecast
$1.72
2027 DPS Forecast
$1.67
2028 DPS Forecast
$1.67
2029 DPS Forecast
$1.67
2030 DPS Forecast
$1.69
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
ALNY Stock Forecast Alnylam Pharmaceuticals Inc Outperform 7
$200.32 $244.18 25.30%
VTRS Stock Forecast Viatris Outperform 8
$9.62 $13.70 40.33%
UTHR Stock Forecast United Therapeutics Outperform 12
$223.94 $280.69 31.73%

Pfizer Inc Free Cash Flow Forecast for 2023 - 2025 - 2030

In the last three years, Pfizer Inc's Free Cash Flow has grown by 309684947.88%, rising from $10.54B to $32647.00T. The next year, 7 experts forecast that Pfizer Inc's Free Cash Flow will decrease by 100.00%, reaching $30.67B. In 2030, professionals predict that Pfizer Inc's Free Cash Flow will decrease by 100.00%, reaching $15.21B.

2023 FCF Forecast
$30.67B
2024 FCF Forecast
$24.18B
2025 FCF Forecast
$23.37B
2026 FCF Forecast
$22.93B
2027 FCF Forecast
$21.67B
2028 FCF Forecast
$16.77B
2029 FCF Forecast
$15.65B
2030 FCF Forecast
$15.21B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
CTLT Stock Forecast Catalent Outperform 15
$65.69 $83.92 11.13%
IONS Stock Forecast Ionis Pharmaceuticals Hold 9
$35.77 $52.42 39.78%
CYTK Stock Forecast Cytokinetics Outperform 10
$35.19 $62.67 70.50%

Pfizer Inc Net Income Forecast for 2023 - 2025 - 2030

In the last three years, Pfizer Inc's Net Income has grown by 95.98%, rising from $16.03B to $31.41B. For next year, analysts predict Net Income of $31.82B, which would mean an increase of 1.32%. According to professionals, by 2030, Pfizer Inc's Net Income will have decreased by 40.08%, falling down to $18.82B.

2023 NI Forecast
$31.82B
2024 NI Forecast
$25.70B
2025 NI Forecast
$24.66B
2026 NI Forecast
$23.88B
2027 NI Forecast
$23.83B
2028 NI Forecast
$20.02B
2029 NI Forecast
$18.84B
2030 NI Forecast
$18.82B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
BCPC Stock Forecast Balchem Outperform 18
$126.48 $163.67 29.66%
NEOG Stock Forecast Neogen Hold 16
$18.52 $37.00 37.69%
CORT Stock Forecast Corcept Therapeutics Outperform 16
$21.64 $0.00 36.32%

Pfizer Inc EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Pfizer Inc's EBITDA has grown, rising from $13.86B to $43.64B – a growth of 214.92%. According to the 10 analysts polled, in the next year, Pfizer Inc's EBITDA will fall by 14.50%, reaching $37.31B. By 2030, professionals believe that Pfizer Inc's EBITDA will have decreased by 55.44%, falling to $19.44B.

2023 EBITDA Forecast
$37.31B
2024 EBITDA Forecast
$31.16B
2025 EBITDA Forecast
$29.88B
2026 EBITDA Forecast
$29.39B
2027 EBITDA Forecast
$29.07B
2028 EBITDA Forecast
$22.41B
2029 EBITDA Forecast
$19.65B
2030 EBITDA Forecast
$19.44B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
TGTX Stock Forecast TG Therapeutics Outperform 9
$15.05 $73.38 26.25%
INDV Stock Forecast Indivior PLC Buy 14
£171.80 £3.79 -97.24%
PCRX Stock Forecast Pacira BioSciences Outperform 16
$40.79 $79.67 91.22%

Pfizer Inc EBIT Forecast for 2023 - 2025 - 2030

Pfizer Inc's EBIT has grown In the last two years, rising from $8.14B to $26.85B – a growth of 229.71%. In the next year, analysts believe that EBIT will reach $33.76B – an increase of 25.78%. By 2030, professionals believe that Pfizer Inc's EBIT will decrease by 19.82%, reaching $21.52B – a concerning trend for the company.

2023 EBIT Forecast
$33.76B
2024 EBIT Forecast
$27.33B
2025 EBIT Forecast
$27.59B
2026 EBIT Forecast
$26.95B
2027 EBIT Forecast
$27.08B
2028 EBIT Forecast
$22.66B
2029 EBIT Forecast
$21.42B
2030 EBIT Forecast
$21.52B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
AMPH Stock Forecast Amphastar Pharmaceuticals Outperform 14
$37.48 $41.00 17.40%
IRWD Stock Forecast Ironwood Pharmaceuticals Hold 14
$10.53 $12.60 18.71%
SUPN Stock Forecast Supernus Pharmaceuticals Outperform 16
$36.28 $35.50 -6.28%

Pfizer Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, Pfizer Inc's EPS has grown by 89.49%, from $2.95 to $5.59. 19 analysts predict Pfizer Inc's EPS will decrease by 2.33% in the next year, reaching $5.46. By 2030, professionals predict that Pfizer Inc's EPS will decrease by 42.04%, to $3.24.

2023 EPS Forecast
$5.46
2024 EPS Forecast
$4.51
2025 EPS Forecast
$4.34
2026 EPS Forecast
$4.22
2027 EPS Forecast
$4.25
2028 EPS Forecast
$3.49
2029 EPS Forecast
$3.24
2030 EPS Forecast
$3.24
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
LGND Stock Forecast Ligand Pharmaceuticals Outperform 14
$73.56 $195.43 115.47%
MDGL Stock Forecast Madrigal Pharmaceuticals Outperform 4
$242.26 $170.08 -27.76%
USNA Stock Forecast USANA Health Sciences Hold 14
$62.90 $104.00 -9.38%